Dr. Pete Campbell of the Casey Eye Institute joins to discuss applications of artificial intelligence for screening of retinopathy of prematurity. 

Relevant Financial Disclosures: Dr. Campbell is co-founder and CEO of Siloam Vision, which is commercializing UWF-OCT, UWF-SLO and AI for ROP.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi